Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Andrew Boyer
Equibles does not estimate personal net worth.
Get an email with a short summary when Amneal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMRX alertsAbout Andrew Boyer
The proxy statement of Amneal Pharmaceuticals, Inc. reports total compensation of $3,017,163 for Andrew Boyer in fiscal 2025, including a base salary of $613,846. Disclosed compensation is on record for 8 fiscal years. Amneal Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amneal Pharmaceuticals, Inc. includes Chintu Patel (CEO and Board Member), Chirag Patel (CEO and Board Member), Paul Meister (Chairman and Board Member) and 7 others.
Affiliation history
-
Amneal Pharmaceuticals, Inc. (AMRX)
Proxy statement
CurrentStart not stated–present
Last confirmed March 25, 2026
Company network
Leadership on record at Amneal Pharmaceuticals, Inc.
- Chintu Patel CEO, Board Member
- Chirag Patel CEO, Board Member
- Paul Meister Chairman, Board Member
- Anastasios (Tasos) G. Konidaris CFO
- Anastasios Konidaris CFO
- Stephen J. Manzano General Counsel
- Deb Autor Board Member
- Deborah M. Autor Board Member
- Gautam Patel Board Member
- J. Kevin Buchi Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Generics | $613,846 | $3,017,163 |
| 2024 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Generics | $600,000 | $2,794,302 |
| 2023 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Generics | $600,000 | $1,942,689 |
| 2022 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Generics | $600,000 | $2,681,937 |
| 2021 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Generics | $600,000 | $2,635,863 |
| 2020 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Generics | $660,084 | $2,386,531 |
| 2019 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Generics | $660,084 | $3,113,079 |
| 2018 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Generics | $412,500 | $3,861,506 |
Recent activity
No call appearances or filed executive changes recorded yet.